ADHD Medication Side Effects UK - What to Expect and How to Manage Them

Methylphenidate (Concerta XL, Ritalin, Medikinet, Equasym) is one of the most commonly prescribed ADHD medications in the UK. Most people tolerate it well, but side effects are common, especially during the first few weeks of treatment and during dose adjustments.

Appetite suppression is the most frequently reported side effect. Many people find they have little or no appetite while the medication is active. This typically improves over the first few weeks as your body adjusts, but some people experience ongoing appetite reduction. Strategies to manage this include eating a substantial breakfast before taking your medication, having calorie-dense snacks available for when you do feel hungry, and eating your main meal in the evening when the medication is wearing off.

Sleep difficulties are common, particularly with longer-acting formulations like Concerta XL. If the medication is still active at bedtime, you may find it hard to fall asleep. Taking your medication earlier in the day often helps. If sleep problems persist, your prescriber may adjust the dose, switch to a shorter-acting formulation, or suggest sleep hygiene strategies.

Headaches are common in the first week or two and usually resolve on their own. Staying hydrated and eating regularly can help. If headaches persist beyond two weeks, speak to your prescriber.

Increased heart rate and slightly elevated blood pressure are expected effects of stimulant medication. These are usually mild and clinically insignificant, but they are monitored regularly during shared care appointments. If you notice your heart racing, feel palpitations, or experience chest pain, contact your GP or prescriber immediately.

Dry mouth, stomach discomfort, and mild anxiety or jitteriness are also reported by some people. These side effects tend to diminish over the first few weeks. If they do not, your prescriber can adjust your dose or try a different formulation.

Lisdexamfetamine, sold as Elvanse in the UK, is a prodrug stimulant. This means it is inactive until your body converts it into its active form (dexamfetamine). This conversion process gives Elvanse a smoother onset and offset than some other stimulants, which can reduce certain side effects.

Appetite suppression is the most common side effect of Elvanse, and it tends to be more pronounced than with methylphenidate. Many people report feeling no hunger at all during the day. The same management strategies apply - eat before taking it, keep snacks available, and eat well in the evening. Weight monitoring during the first year is important.

Sleep disturbance is less common with Elvanse than some people expect, because the medication wears off gradually rather than abruptly. However, if you take Elvanse too late in the day, it can still affect your sleep. Most prescribers recommend taking it first thing in the morning.

The "crash" effect - a sudden dip in mood and energy as the medication wears off - is reported by some Elvanse users, though it tends to be milder than with methylphenidate. If you experience a noticeable crash, discuss it with your prescriber. Adjusting the dose or timing can often help.

Dry mouth is very common with Elvanse. Keep water with you throughout the day. Sugar-free chewing gum can also help. Some people find that dry mouth persists long-term, while for others it resolves after the first few weeks.

Emotional flatness or feeling "too focused" is reported by some people on Elvanse. If you feel like the medication is dampening your personality, emotions, or creativity, tell your prescriber. This can often be addressed by adjusting the dose. The goal is to improve focus without losing yourself.

Atomoxetine (Strattera) is a non-stimulant ADHD medication that works by increasing noradrenaline levels in the brain. It takes longer to reach full effect than stimulants - typically four to six weeks - so the side effect profile is different.

Nausea and stomach discomfort are the most common side effects when starting atomoxetine. Taking it with food significantly reduces this. Most people find nausea improves within the first two weeks. If it persists, your prescriber may suggest splitting the dose between morning and evening.

Fatigue and drowsiness are common in the first week or two. Atomoxetine does not have the energising effect of stimulants, and many people feel tired initially. This usually passes as your body adjusts. Taking the medication in the evening can help if daytime drowsiness is an issue.

Decreased appetite occurs with atomoxetine but is generally less severe than with stimulant medications. Weight loss is possible but typically modest compared to stimulant-associated weight loss.

Mood changes, including increased irritability or low mood, are reported by some people, particularly in the first few weeks. These should be monitored carefully. In rare cases, atomoxetine can increase suicidal thoughts, especially in young adults. If you experience significant mood changes, contact your prescriber immediately.

Sexual side effects, including reduced libido and difficulty achieving orgasm, are more common with atomoxetine than with stimulant medications. These are worth discussing openly with your prescriber, as they can significantly affect quality of life. Dose adjustments or switching medication may help.

The "crash" is the term used to describe the sudden drop in focus, mood, and energy that some people experience as their stimulant medication wears off. It is more common with shorter-acting formulations but can occur with any stimulant.

The crash typically happens in the late afternoon or early evening, depending on when you took your medication and which formulation you are on. Symptoms can include irritability, sadness, fatigue, difficulty concentrating, restlessness, and sometimes intense hunger as your suppressed appetite returns.

Not everyone experiences a crash. Some people notice a gradual return to their unmedicated state without any dramatic dip. Others experience a pronounced crash that significantly affects their evening functioning and relationships.

Strategies to manage the crash include: eating a protein-rich snack before the medication wears off, scheduling less demanding tasks for the crash period, having a short period of rest or light exercise when you feel the dip, and communicating with household members about what you are experiencing so they can be understanding.

If the crash is severe or disruptive, discuss it with your prescriber. Options include switching to a longer-acting formulation (which wears off more gradually), adding a small short-acting booster dose in the afternoon, or switching to a different medication entirely. The crash is a manageable side effect, not something you should simply endure.

Cardiovascular effects are one of the most important areas of monitoring for ADHD medication. All stimulant medications can increase heart rate and blood pressure. Understanding this helps you stay informed and engaged with your monitoring.

On average, stimulant medications increase heart rate by 5 to 10 beats per minute and systolic blood pressure by 2 to 5 mmHg. For most healthy adults, these increases are clinically insignificant and well within safe ranges. However, they need monitoring because in rare cases, more significant increases can occur.

Before starting ADHD medication, your prescriber should check your baseline blood pressure, heart rate, and ask about family history of heart problems. If you have a pre-existing heart condition, a family history of sudden cardiac death, or significantly elevated blood pressure, your prescriber will assess the risks carefully before prescribing.

During shared care, your GP will check your blood pressure and heart rate at regular intervals (usually every six months). If readings are consistently elevated, they may refer you back to the specialist or reduce your dose.

You should seek immediate medical attention if you experience chest pain, shortness of breath at rest, fainting, or a very rapid or irregular heartbeat while taking ADHD medication. These symptoms are rare but need urgent assessment.

Sleep difficulties are one of the most common side effects of stimulant ADHD medication, and they are also one of the most manageable. Understanding why they happen helps you take effective action.

Stimulant medications increase alertness and arousal, which is exactly what you want during the day but unhelpful at bedtime. The key factor is timing - how long the medication lasts and when you take it. Longer-acting formulations (Concerta XL, Elvanse) last 10 to 14 hours, so a dose taken at 8am should wear off by 6 to 10pm.

If you are struggling to fall asleep, the first step is to review your medication timing. Taking your dose earlier in the morning often solves the problem. If you are currently taking it at 9am, try 7am and see whether sleep improves over the next few days.

Good sleep hygiene becomes even more important when taking ADHD medication. Avoid caffeine after midday (it amplifies the stimulant effect), keep a consistent bedtime, limit screen time in the hour before bed, and keep your bedroom cool and dark.

Some prescribers recommend melatonin (available on prescription in the UK) if sleep difficulties persist despite good timing and sleep hygiene. Melatonin is well-tolerated and does not interact with ADHD medication.

Paradoxically, some people with ADHD actually find that medication improves their sleep. This is because untreated ADHD itself causes racing thoughts and restlessness at bedtime. Once the brain is regulated during the day, the evening wind-down can actually be easier. If your sleep worsens on medication, tell your prescriber, but if it improves, that is a sign the medication is working well for you.

Long-term effects of ADHD medication are a common concern for people starting treatment. The evidence base for adult ADHD medication is now substantial, and the overall picture is reassuring.

Methylphenidate and amphetamine-based medications (including Elvanse) have been used for decades. Long-term studies consistently show that the benefits of treatment - improved focus, better work performance, reduced accident risk, improved relationships, and better emotional regulation - outweigh the risks for most people.

There is no evidence that ADHD stimulant medication causes brain damage, personality changes, or long-term cognitive decline when used as prescribed. The myth that stimulants are harmful long-term largely stems from confusion between therapeutic use and substance misuse, which are entirely different contexts.

The main long-term consideration is cardiovascular health. Long-term stimulant use is associated with small, sustained increases in blood pressure and heart rate. For most adults, this is not clinically significant, but regular monitoring ensures any concerning trends are caught early.

Weight management is another long-term consideration. Stimulant-related appetite suppression can lead to gradual weight loss. While this is sometimes welcomed, unintended significant weight loss should be discussed with your GP. Ensuring adequate nutrition is important even when you do not feel hungry.

The biggest long-term risk of ADHD medication is often not the medication itself, but stopping it without support. Untreated ADHD is associated with higher rates of unemployment, relationship breakdown, substance misuse, accidents, and mental health difficulties. For many people, the risks of not treating ADHD are greater than the risks of medication.

Most ADHD medication side effects are mild and resolve within the first few weeks of treatment. However, some side effects need prompt medical attention. Knowing the difference helps you respond appropriately.

Contact your prescriber (not necessarily as an emergency) if you experience: persistent headaches beyond the first two weeks, ongoing sleep difficulties despite adjusting timing, sustained appetite loss leading to noticeable weight loss, mood changes including increased anxiety, irritability, or low mood, or any sexual side effects you want to discuss.

Seek urgent medical attention (call 111 or attend A&E) if you experience: chest pain or tightness, a very rapid or irregular heartbeat, fainting or near-fainting, severe allergic reaction (rash, swelling, difficulty breathing), or suicidal thoughts (particularly relevant for atomoxetine).

Do not stop your medication suddenly without medical advice. While stimulant medications do not cause physical withdrawal, stopping abruptly can lead to a sudden return of ADHD symptoms, rebound effects, and low mood. If you want to stop or change your medication, discuss it with your prescriber first.

Keep a side effect diary during the first few months of treatment. Note what you experience, when it happens, how severe it is, and whether it improves over time. This information is invaluable at your next review appointment and helps your prescriber make informed adjustments.

Some people decide to stop ADHD medication temporarily or permanently. Understanding how to do this safely ensures you make the transition without unnecessary difficulty.

Stimulant medications (methylphenidate and lisdexamfetamine) do not cause physical dependence in the way that some other medications do. You can stop taking them without a gradual taper. However, the sudden return of ADHD symptoms can be quite jarring, especially if you have been on medication for months or years.

If you are considering stopping, discuss it with your prescriber. They can help you plan the timing (avoiding high-stress periods at work, for example), put support strategies in place, and schedule a follow-up to assess how you are managing.

Some people take planned medication breaks, sometimes called "drug holidays." This might mean not taking medication on weekends, during holidays, or during less demanding periods. Drug holidays can help manage side effects like appetite suppression and allow you to assess how well you function without medication. Discuss this approach with your prescriber before trying it.

Non-stimulant medications like atomoxetine should be tapered gradually rather than stopped suddenly. Your prescriber will give you a reduction schedule. Stopping atomoxetine abruptly can cause nausea, anxiety, and mood disturbance.

Managing ADHD medication is an ongoing process, and My ADHD Path offers tools to support you at every stage.

My Pro AI Chat can help you understand your medication options, discuss side effects you are experiencing, and prepare for conversations with your prescriber. It is not a substitute for medical advice, but it can help you formulate questions and understand your options.

My Letter Templates include letters for communicating with your GP about shared care, requesting medication reviews, and escalating if your GP is not providing adequate monitoring.

For a detailed guide to shared care agreements, which are essential for ongoing medication management, see our guide on shared care agreements in the UK. For information on assessment costs including medication costs after diagnosis, see our guide on ADHD assessment costs.